Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research
Clinical trial NCT05885776 · UNKNOWN
Trial details
- NCT number
- NCT05885776
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2024-03-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.